Corporate ActionMay 12, 2026, 04:19 PM
IceCure Medical Enters At-The-Market Equity Offering Agreement
AI Summary
IceCure Medical Ltd. has entered into a Sales Agreement with A.G.P./Alliance Global Partners to offer and sell ordinary shares from time to time through an "at the market offering." The company is not obligated to sell shares but can do so based on its instructions, with the Sales Agent using commercially reasonable efforts. The net proceeds from any sales are intended for working capital and general corporate purposes, and the company will pay a 3.0% commission on gross proceeds.
Key Highlights
- IceCure Medical entered a Sales Agreement with A.G.P./Alliance Global Partners.
- The company may offer and sell ordinary shares through an "at the market offering" (ATM).
- The Sales Agent will use commercially reasonable efforts to sell shares based on company instructions.
- Net proceeds from the sale of securities are intended for working capital and general corporate purposes.
- IceCure Medical will pay the Sales Agent a commission of 3.0% of the aggregate gross proceeds.
Price Impact
More from ICCM